You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Express Scripts
McKesson
Baxter
Harvard Business School
Colorcon
Boehringer Ingelheim

Last Updated: February 17, 2020

DrugPatentWatch Database Preview

Eastman Kodak Company Profile


Email this page to a colleague

See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for EASTMAN KODAK, and what generic and branded alternatives to EASTMAN KODAK drugs are available?

EASTMAN KODAK has three approved drugs.



Summary for Eastman Kodak
US Patents:0
Tradenames:5
Ingredients:5
NDAs:3

Drugs and US Patents for Eastman Kodak

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Eastman Kodak RAVOCAINE AND NOVOCAIN W/ LEVOPHED norepinephrine bitartrate; procaine hydrochloride; propoxycaine hydrochloride INJECTABLE;INJECTION 008592-003 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial
Eastman Kodak LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE epinephrine; lidocaine hydrochloride INJECTABLE;INJECTION 040057-001 Feb 26, 1993 DISCN No No   Start Trial   Start Trial
Eastman Kodak LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE epinephrine; lidocaine hydrochloride INJECTABLE;INJECTION 040057-002 Feb 26, 1993 DISCN No No   Start Trial   Start Trial
Eastman Kodak RAVOCAINE AND NOVOCAIN W/ NEO-COBEFRIN levonordefrin; procaine hydrochloride; propoxycaine hydrochloride INJECTABLE;INJECTION 008592-007 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial
Eastman Kodak CARBOCAINE W/ NEO-COBEFRIN levonordefrin; mepivacaine hydrochloride INJECTABLE;INJECTION 012125-002 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial
Eastman Kodak CARBOCAINE mepivacaine hydrochloride INJECTABLE;INJECTION 012125-003 Approved Prior to Jan 1, 1982 DISCN Yes No   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Merck
Mallinckrodt
Johnson and Johnson
Baxter
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.